NCT05969392View on ClinicalTrials.gov

Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

April 30, 2026

Conditions
Pain, CervicalDiscogenic Pain
Interventions
DEVICE

Intradiscal Gelified Ethanol (Discogel)

Intradiscal percutaneous injection of an intradiscal Gelified Ethanol

Trial Locations (2)

9121

Santissima Trinità Hospital Ascagliari, Cagliari

53000

Azienda Ospedaliera Universitaria, Siena

All Listed Sponsors
lead

Gelscom SAS

INDUSTRY

NCT05969392 - Evaluation of Efficacy and Safety of Intradiscal Gelified Ethanol in Refractory Cervical Discogenic Pain | Biotech Hunter | Biotech Hunter